Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1993-04-02
1994-12-13
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514824, 514293, 514294, A61K 31675, A61K 3144
Patent
active
053729994
ABSTRACT:
The invention relates to the use of magnesium-pyridoxal-5'-phosphate-glutaminate to prepare a pharmaceutical suitable for the reduction of LDL-bound peroxides and for the prophylaxis of vascular lesions resulting therefrom in the absence of hypercholesteraemia or hyperlipidaemia.
REFERENCES:
patent: 4925672 (1990-05-01), Gremm
CA:105(19)164785x (1986).
CA:86(16)111179k (1977).
CA:94(25) 204328p (1981).
Steadman's Medical Dictionary, Twenty-second edition p. 123 (1972).
Marshall et al., Beeinflussen die . . . medikamentose Lipidsenkung?, Apr. 1986, Therapiewoche, vol. 36, No. 15, pp. 1549-1561.
Wieland, MPPG gehort . . . medikamentosen Lipidsenkung, Feb. 1990, Fortschritte der Medizin, vol. 108, Supplement 1, pp. 52-53.
Elstner Erich F.
Meyer Britta
Schneider Werner
Cintins Marianne M.
Criares T. J.
Steigerwald Arzneimittelwerk GmbH
LandOfFree
Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prev does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prev, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prev will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1193532